News | May 18, 2026
Amrutanjan Healthcare expands portfolio in pain management
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
